The search for a cure: latest news

The search for a cure resources

The search for a cure features

The search for a cure news from aidsmap

More news

The search for a cure news selected from other sources

  • 'Molecular microscope' finds hidden AIDS virus in the body

    Researchers have developed a sophisticated new probe that detects HIV’s hiding places inside and outside of cells. Insights from this high-powered molecular microscope, revealed at an international AIDS conference last week, may clarify critical questions about HIV persistence and, ultimately, about how to rid the body of the virus.

    27 July 2015 | Science
  • Bold goal of stopping HIV is motivating great science

    The massive challenge of finding an HIV vaccine has unleashed stunning creativity in laboratories all over the world. While we work toward the long-term goal of a vaccine, we are also pulling in partners from many sectors to improve prevention, treatment, and access to options in the short term.

    13 July 2015 | Devex
  • Scripps Research Institute-Designed Drug Candidate Significantly Reduces HIV Reactivation Rate

    HIV-infected patients remain on antiretroviral therapy for life because the virus survives over the long-term in infected dormant cells. Interruption of current types of antiretroviral therapy results in a rebound of the virus and clinical progression to AIDS. But now, scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown that, unlike other antiretroviral therapies, a natural compound called Cortistatin A reduces residual levels of virus from these infected dormant cells, establishing a near-permanent state of latency and greatly diminishing the virus’ capacity for reactivation.

    11 July 2015 | Scripps Research Institute
  • Risks vs rewards: why people with HIV volunteer for 'cure' research

    A recent survey of people living with HIV in the United Kingdom found that more than half would participate in a clinical study to develop a cure for HIV, despite this posing a risk to their health. Why would someone choose to do this?

    24 June 2015 | The Conversation
  • Perspectives on Post-Treatment Control of HIV

    Several recent papers offer perspectives on the possibility of achieving post-treatment control of HIV replication by starting antiretroviral therapy (ART) during acute infection.

    03 June 2015 | The Body
  • Is Gilead Sciences Its Own Worst Enemy?

    Gilead's science is so good that it's actually destroying the company's business. Pharma companies, like most other businesses, make the bulk of their money through repeat business. Gilead, however, is doing something really no other drugmaker is doing -- namely curing patients of devastating infectious diseases.

    20 May 2015 | Motley Fool
  • HIV immunity: rare gene differences offer hope for treatment

    Seven years after the ‘Berlin patient’ was cured of HIV, scientists are looking to natural immunity through genetic variation to create vaccine and gene therapies

    12 May 2015 | The Guardian
  • GSK team up with US researchers to advance search for HIV cure

    Pharmaceutical giant GlaxoSmithKline have partnered with researchers from UNC-Chapel Hill to create a research center that will focus on finding a cure for HIV.

    12 May 2015 | HIV / AIDS News From Medical News Today
  • Researchers “un-can” the HIV virus

    If the human immunodeficiency virus (HIV) is a bit like a hermetically sealed tin can no one has yet been able to break open, the good news is that researchers at the CHUM Research Centre, affiliated with the University of Montreal, have identified a way to use a “can opener” to force the virus to open up and to expose its vulnerable parts, allowing the immune system cells to then kill the infected cells.

    05 May 2015 | Univesity of Montreal
  • Six questions about HIV/AIDS that deserve more attention

    As HIV investigators work to control and eradicate the virus worldwide, certain myths or misconceptions about the disease have been embraced, whereas other concepts with merit have been left relatively unexplored, argues American HIV/AIDS researcher Jay Levy, M.D., in a Trends in Molecular Medicine commentary. He calls on fellow researchers to continue questioning and not to lose sight of alternative strategies that could ultimately lead to a sustainable, long-term solution to HIV infection.

    15 April 2015 | Eurekalert Inf Dis
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.